Search results
Merck to Acquire EyeBio
Morningstar· 15 hours agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today ...
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
Reuters via Yahoo Finance· 15 hours ago(Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion,...
Merck KGaA (MKGAF) Upgraded to Buy: Here's What You Should Know
Zacks via Yahoo Finance· 10 hours agoMerck KGaA (MKGAF) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2...
Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent
Quartz· 11 hours agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer...
FDA sets review date for Merck's KEYTRUDA in mesothelioma treatment By Investing.com
Investing.com· 9 hours agoMerck & Co., Inc., a global healthcare leader, has announced that the U.S. Food and Drug...
Merck eyes purchase of ophthalmology company
WFMZ Eastern Pennsylvania and Western New Jersey· 4 hours agoTake Merck, for example. Its blockbuster cancer drug, Keytruda, is now the largest selling drug in the world. In the past few weeks, studies have shown...
Surmodics Stock Rockets, But Merck Stock Little Moved, On Takeover Deals
Investor's Business Daily· 6 hours agoDow Jones stalwart Merck and Surmodics announced big takeover deals Wednesday, but Merck stock...
Merck to Buy Eye Drug Company Eyebiotech for Up to $3 Billion. It’s Doubling Down on Deals.
Barrons.com· 13 hours agoThe pharmaceutical company agrees to buy eye drug company Eyebiotech for up to $3 billion as it...
Merck Nears $1.3 Billion Cash Deal for Eye-Drug Company EyeBio, WSJ Reports
US News & World Report· 1 day agoMerck did not immediately respond to Reuters' request for a comment, while Eyebiotech declined to comment. Eyebiotech is a clinical stage opthalmology company, with operations ...
Merck To Pay as Much as $3 Billion for Eye Treatment Startup
Bloomberg· 15 hours agoHave a confidential tip for our reporters? Merck & Co. restocked its cabinet of eye treatments with...
